30.64 USD
↗ 1.51 (5.18%)AT CLOSE (11:59 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
29.70
↘ 0.95 (3.08%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
29.70
↘ 0.95 (3.08%)
Market: CLOSED
GH Research PLC Ordinary Shares (GHRS) trades at $30.58 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 6, 2026.
Open?$29.34
High?$30.90
Low?$28.82
Prev. Close?$29.13
Volume?486.6K
Avg. Volume?N/A
VWAP?$29.81
Bid / Ask
Bid?$25.01 × 100
Ask?$34.73 × 100
Spread?$9.72
Midpoint?$29.87
Valuation & Ratios
Market Cap?2.0B
Shares Out?68.6M
Float?36.4M
Float %?53.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?250.67Safe
Confidence?31%Very Low
Short InterestVery High
Short % of Float?5.34%Elevated
Short Interest?1.9M
Days to Cover?10.5
Free Float36.4M
Avg Daily Volume185.7K
Settlement Date2026-07-15